Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 18 Aug 2026. Factsheet Jun 2026. About · Disclosures
Tata India Pharma and Healthcare Fund Direct Plan Growth
Tata Mutual FundSectoral Pharma and HealthcareDirectGrowth
NAV
₹39.7747
As on 18 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +9.62% | — | — |
| 3 year | +20.31% | — | — |
| 5 year | +15.52% | — | — |
- Sharpe
- 1.00
- Std dev
- 17.12%
- Beta
- 1.00
Returns
From NAVs through 18 Aug 2026
1Y
+9.62%
Total
3Y
+20.31%
p.a.
5Y
+15.52%
p.a.
SI
+16.04%
p.a.
Calendar years
-6.64%2022
+38.59%2023
+42.48%2024
-3.47%2025
+12.45%2026 YTD
Rolling 1-year · 51 overlapping windows
-7.67%avg +17.67%+62.09%
Fund facts
Fund details from the Jun 2026 factsheet
Fund size
₹1,455.16 Cr
Expense ratio
0.67%
Exit load
None
Lock-in
None
Launched28 Dec 2015
StructureOpen Ended
ISININF277K019A3
Where the money is invested
Split by asset type.
By asset type
Equity99.30%
Cash0.70%
What the fund holds
42 holdings · portfolio as on 30 May 2026
- 9.38%Sun Pharmaceuticals Industries LtdHealthcare
- 5.87%Healthcare Global Enterprises LtdHealthcare
- 5.8%Divi's Laboratories LtdHealthcare
- 5.41%Abbott India LtdHealthcare
- 5.18%Cipla LtdHealthcare
- 4.8%Max Healthcare Institute Ltd Ordinary SharesHealthcare
- 4.56%Apollo Hospitals Enterprise LtdHealthcare
- 4.52%Rainbow Childrens Medicare LtdHealthcare
- 4.02%Dr Reddy's Laboratories LtdHealthcare
- 3.77%Mankind Pharma LtdHealthcare
Concentration
Top 5 weight
31.64%
Top 10 weight
53.31%
Avg turnover
43.33%
Risk and quality measures
How steady the returns have been.
Return quality
Sharpe
1
Better than category avg 0.98
Sortino
1.32
Return per unit of downside risk
Alpha
-1.02
Return above the benchmark
Risk
Std deviation
17.12%
How much returns swing
Beta
1
Below category avg 0.95
R-squared
97.4%
How closely it tracks the benchmark
Who manages this fund
1 fund manager
- RSRajat Srivastava1.4 years in the industryRuns 1 scheme
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare- ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare- Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
Rate
+20.31%
Invested
₹6,00,000
Illustrated
₹19,51,318
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- regularGrowthTata India Pharma and Healthcare Fund Regular Plan GrowthNAV ₹30.6771
- regularIDCWTata India Pharma and Healthcare Fund Regular Plan IDCW PayoutNAV ₹30.6771
- directIDCWTata India Pharma and Healthcare Fund Direct Plan IDCW PayoutNAV ₹35.8833
- directIDCWTata India Pharma and Healthcare Fund Direct Plan IDCW PayoutNAV ₹35.8833
- regularIDCWTata India Pharma and Healthcare Fund Regular Plan IDCW PayoutNAV ₹30.6771
FAQ
What is Tata India Pharma and Healthcare Fund Direct Plan Growth NAV today?
- The latest NAV of Tata India Pharma and Healthcare Fund Direct Plan Growth is ₹39.7747 as on 18 Aug 2026.
How has Tata India Pharma and Healthcare Fund Direct Plan Growth performed vs its category?
- 1-year return +9.62%. Past performance does not guarantee future returns.
What are the returns of Tata India Pharma and Healthcare Fund Direct Plan Growth?
- Trailing returns from published NAVs: 1 year +9.62%, 3 year +20.31% a year, 5 year +15.52% a year, since our first NAV +16.04% a year. Past performance does not guarantee future returns.
How would a SIP in Tata India Pharma and Healthcare Fund Direct Plan Growth have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +20.31%. It is not a forecast.
What is the expense ratio and fund size of Tata India Pharma and Healthcare Fund Direct Plan Growth?
- For Tata India Pharma and Healthcare Fund Direct Plan Growth, the expense ratio is 0.67% and fund size (AUM) is ₹1,455.16 Cr.
What is the ISIN of Tata India Pharma and Healthcare Fund Direct Plan Growth?
- The ISIN for Tata India Pharma and Healthcare Fund Direct Plan Growth is INF277K019A3.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.